96 related articles for article (PubMed ID: 15458748)
21. The effect of interleukin-1 on cytokine gene expression by human corneal epithelial cells.
Narayanan S; Glasser A; Hu YS; McDermott AM
Exp Eye Res; 2005 Feb; 80(2):175-83. PubMed ID: 15670796
[TBL] [Abstract][Full Text] [Related]
22. The role of progesterone and its receptor on cyclin G1 expression in endometrial carcinoma cells.
Liu F; Gao X; Yu H; Yuan D; Zhang J; He Y; Yue L
Reprod Sci; 2012 Nov; 19(11):1205-10. PubMed ID: 22649121
[TBL] [Abstract][Full Text] [Related]
23. Expression of estrogen receptors alpha and beta, and progesterone receptors A and B in human mucinous carcinoma of the endometrium.
Shabani N; Mylonas I; Jeschke U; Thaqi A; Kuhn C; Puchner T; Friese K
Anticancer Res; 2007; 27(4A):2027-33. PubMed ID: 17649817
[TBL] [Abstract][Full Text] [Related]
24. Oestrogen regulated gene expression in normal and malignant endometrial tissue.
O'Toole SA; Dunn E; Sheppard BL; Sheils O; O'Leary JJ; Wuttke W; Seidlova-Wuttke D
Maturitas; 2005 Jun; 51(2):187-98. PubMed ID: 15917160
[TBL] [Abstract][Full Text] [Related]
25. Progesterone receptor isoforms profile, modulate matrix metalloproteinase 2 expression in the decidua.
Goldman S; Shalev E
Am J Obstet Gynecol; 2007 Dec; 197(6):604.e1-8. PubMed ID: 17678863
[TBL] [Abstract][Full Text] [Related]
26. The hormone replacement therapy drug tibolone acts very similar to medroxyprogesterone acetate in an estrogen-and progesterone-responsive endometrial cancer cell line.
Hanifi-Moghaddam P; Sijmons B; Ott MC; van Ijcken WF; Nowzari D; Kuhne EC; van der Spek P; Kloosterboer HJ; Burger CW; Blok LJ
J Mol Endocrinol; 2006 Dec; 37(3):405-13. PubMed ID: 17170081
[TBL] [Abstract][Full Text] [Related]
27. Drastic decrease of progesterone receptor form B but not A mRNA reflects poor patient prognosis in endometrial cancers.
Sakaguchi H; Fujimoto J; Hong BL; Nakagawa Y; Tamaya T
Gynecol Oncol; 2004 May; 93(2):394-9. PubMed ID: 15099952
[TBL] [Abstract][Full Text] [Related]
28. [BRCA1 regulates progesterone receptors A and B protein expressions in breast cancer cells in vitro].
Guo YX; Zeng WS; Liu YW; Li YS; Lin J; Xiong JB; Luo SQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1157-60. PubMed ID: 18676251
[TBL] [Abstract][Full Text] [Related]
29. Up-regulation of nuclear receptor corepressor (NCoR) in progestin-induced growth suppression of endometrial hyperplasia and carcinoma.
Kashima H; Horiuchi A; Uchikawa J; Miyamoto T; Suzuki A; Ashida T; Konishi I; Shiozawa T
Anticancer Res; 2009 Apr; 29(4):1023-9. PubMed ID: 19414341
[TBL] [Abstract][Full Text] [Related]
30. Direct progesterone receptor and indirect androgen receptor interactions with the kallikrein-related peptidase 4 gene promoter in breast and prostate cancer.
Lai J; Myers SA; Lawrence MG; Odorico DM; Clements JA
Mol Cancer Res; 2009 Jan; 7(1):129-41. PubMed ID: 19147544
[TBL] [Abstract][Full Text] [Related]
31. Effect of initial subcellular localization of progesterone receptor on import kinetics and transcriptional activity.
Li H; Fidler ML; Lim CS
Mol Pharm; 2005; 2(6):509-18. PubMed ID: 16323958
[TBL] [Abstract][Full Text] [Related]
32. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
33. Interleukin 1beta and progesterone stimulate activin a expression and secretion from cultured human endometrial stromal cells.
Florio P; Rossi M; Viganò P; Luisi S; Torricelli M; Torres PB; Di Blasio AM; Petraglia F
Reprod Sci; 2007 Jan; 14(1):29-36. PubMed ID: 17636213
[TBL] [Abstract][Full Text] [Related]
34. Expression of cyclooxygenase-2 in uterine endometrial cancer and anti-tumor effects of a selective COX-2 inhibitor.
Hasegawa K; Ohashi Y; Ishikawa K; Yasue A; Kato R; Achiwa Y; Nishio E; Udagawa Y
Int J Oncol; 2005 May; 26(5):1419-28. PubMed ID: 15809736
[TBL] [Abstract][Full Text] [Related]
35. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
36. Tumor suppressor effect of follistatin-like 1 in ovarian and endometrial carcinogenesis: a differential expression and functional analysis.
Chan QK; Ngan HY; Ip PP; Liu VW; Xue WC; Cheung AN
Carcinogenesis; 2009 Jan; 30(1):114-21. PubMed ID: 18796737
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
[TBL] [Abstract][Full Text] [Related]
38. Glucocorticoids inhibit cell death in ovarian cancer and up-regulate caspase inhibitor cIAP2.
Runnebaum IB; Brüning A
Clin Cancer Res; 2005 Sep; 11(17):6325-32. PubMed ID: 16144937
[TBL] [Abstract][Full Text] [Related]
39. Differences in invasive capacity of endometrial cancer cell lines expressing different progesterone receptor isotypes: possible involvement of cadherins.
Hanekamp EE; Gielen SC; De Ruiter PE; Chadha-Ajwani S; Huikeshoven FJ; Burger CW; Grootegoed JA; Blok LJ
J Soc Gynecol Investig; 2005 May; 12(4):278-84. PubMed ID: 15866121
[TBL] [Abstract][Full Text] [Related]
40. Progesterone receptor isoform identification and subcellular localization in endometrial cancer.
Leslie KK; Stein MP; Kumar NS; Dai D; Stephens J; Wandinger-Ness A; Glueck DH
Gynecol Oncol; 2005 Jan; 96(1):32-41. PubMed ID: 15589577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
